The Anti-Aging and Tumor Suppressor Protein Klotho Enhances Differentiation of a Human Oligodendrocytic Hybrid Cell Line

Ci Di Chen, Hu Li, Jennifer Liang, Kathryn Hixson, Ella Zeldich, Carmela R. Abraham

Research output: Contribution to journalArticle

  • 16 Citations

Abstract

Klotho functions as an aging suppressor, which, in mice, extends lifespan when overexpressed and accelerates development of aging-like phenotypes when disrupted. Klotho is mainly expressed in brain and kidney and is secreted into the serum and CSF. We have previously shown that Klotho is reduced in brains of old monkeys, rats, and mice. We further reported the ability of Klotho to enhance oligodendrocyte differentiation and myelination. Here, we examined the signaling pathways induced by Klotho in MO3.13, a human oligodendrocytic hybrid cell line. We show that exogenous Klotho affects the ERK and Akt signaling pathways, decreases the proliferative abilities and enhances differentiation of MO3.13 cells. Furthermore, microarray analysis of Klotho-treated MO3.13 cells reveals a massive change in gene expression with 80 % of the differentially expressed genes being downregulated. Using gene set enrichment analysis, we predicted potential transcription factors involved in regulating Klotho-treated MO3.13 cells and found that these cells are highly enriched in the gene sets, that are similarly observed in cancer, cardiovascular disease, stress, aging, and hormone-related chemical and genetic perturbations. Since Klotho is downregulated in all brain tumors tested to date, enhancing Klotho has therapeutic potential for treating brain and other malignancies.

LanguageEnglish (US)
Pages76-90
Number of pages15
JournalJournal of Molecular Neuroscience
Volume55
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Tumor Suppressor Proteins
Hybrid Cells
Cell Line
Brain
Down-Regulation
Genes
Oligodendroglia
Microarray Analysis
Brain Neoplasms
Haplorhini
Cell Differentiation
Neoplasms
Transcription Factors
Cardiovascular Diseases
Hormones
Phenotype
Kidney
Gene Expression
Serum
Therapeutics

Keywords

  • Aging
  • Apoptosis
  • Cancer
  • ERK
  • Glia
  • Myelin
  • Signaling pathways

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Medicine(all)

Cite this

The Anti-Aging and Tumor Suppressor Protein Klotho Enhances Differentiation of a Human Oligodendrocytic Hybrid Cell Line. / Chen, Ci Di; Li, Hu; Liang, Jennifer; Hixson, Kathryn; Zeldich, Ella; Abraham, Carmela R.

In: Journal of Molecular Neuroscience, Vol. 55, No. 1, 2014, p. 76-90.

Research output: Contribution to journalArticle

Chen, Ci Di ; Li, Hu ; Liang, Jennifer ; Hixson, Kathryn ; Zeldich, Ella ; Abraham, Carmela R./ The Anti-Aging and Tumor Suppressor Protein Klotho Enhances Differentiation of a Human Oligodendrocytic Hybrid Cell Line. In: Journal of Molecular Neuroscience. 2014 ; Vol. 55, No. 1. pp. 76-90
@article{3aace6e12e984abc955c5a1efa30626d,
title = "The Anti-Aging and Tumor Suppressor Protein Klotho Enhances Differentiation of a Human Oligodendrocytic Hybrid Cell Line",
abstract = "Klotho functions as an aging suppressor, which, in mice, extends lifespan when overexpressed and accelerates development of aging-like phenotypes when disrupted. Klotho is mainly expressed in brain and kidney and is secreted into the serum and CSF. We have previously shown that Klotho is reduced in brains of old monkeys, rats, and mice. We further reported the ability of Klotho to enhance oligodendrocyte differentiation and myelination. Here, we examined the signaling pathways induced by Klotho in MO3.13, a human oligodendrocytic hybrid cell line. We show that exogenous Klotho affects the ERK and Akt signaling pathways, decreases the proliferative abilities and enhances differentiation of MO3.13 cells. Furthermore, microarray analysis of Klotho-treated MO3.13 cells reveals a massive change in gene expression with 80 {\%} of the differentially expressed genes being downregulated. Using gene set enrichment analysis, we predicted potential transcription factors involved in regulating Klotho-treated MO3.13 cells and found that these cells are highly enriched in the gene sets, that are similarly observed in cancer, cardiovascular disease, stress, aging, and hormone-related chemical and genetic perturbations. Since Klotho is downregulated in all brain tumors tested to date, enhancing Klotho has therapeutic potential for treating brain and other malignancies.",
keywords = "Aging, Apoptosis, Cancer, ERK, Glia, Myelin, Signaling pathways",
author = "Chen, {Ci Di} and Hu Li and Jennifer Liang and Kathryn Hixson and Ella Zeldich and Abraham, {Carmela R.}",
year = "2014",
doi = "10.1007/s12031-014-0336-1",
language = "English (US)",
volume = "55",
pages = "76--90",
journal = "Journal of Molecular Neuroscience",
issn = "0895-8696",
publisher = "Humana Press",
number = "1",

}

TY - JOUR

T1 - The Anti-Aging and Tumor Suppressor Protein Klotho Enhances Differentiation of a Human Oligodendrocytic Hybrid Cell Line

AU - Chen,Ci Di

AU - Li,Hu

AU - Liang,Jennifer

AU - Hixson,Kathryn

AU - Zeldich,Ella

AU - Abraham,Carmela R.

PY - 2014

Y1 - 2014

N2 - Klotho functions as an aging suppressor, which, in mice, extends lifespan when overexpressed and accelerates development of aging-like phenotypes when disrupted. Klotho is mainly expressed in brain and kidney and is secreted into the serum and CSF. We have previously shown that Klotho is reduced in brains of old monkeys, rats, and mice. We further reported the ability of Klotho to enhance oligodendrocyte differentiation and myelination. Here, we examined the signaling pathways induced by Klotho in MO3.13, a human oligodendrocytic hybrid cell line. We show that exogenous Klotho affects the ERK and Akt signaling pathways, decreases the proliferative abilities and enhances differentiation of MO3.13 cells. Furthermore, microarray analysis of Klotho-treated MO3.13 cells reveals a massive change in gene expression with 80 % of the differentially expressed genes being downregulated. Using gene set enrichment analysis, we predicted potential transcription factors involved in regulating Klotho-treated MO3.13 cells and found that these cells are highly enriched in the gene sets, that are similarly observed in cancer, cardiovascular disease, stress, aging, and hormone-related chemical and genetic perturbations. Since Klotho is downregulated in all brain tumors tested to date, enhancing Klotho has therapeutic potential for treating brain and other malignancies.

AB - Klotho functions as an aging suppressor, which, in mice, extends lifespan when overexpressed and accelerates development of aging-like phenotypes when disrupted. Klotho is mainly expressed in brain and kidney and is secreted into the serum and CSF. We have previously shown that Klotho is reduced in brains of old monkeys, rats, and mice. We further reported the ability of Klotho to enhance oligodendrocyte differentiation and myelination. Here, we examined the signaling pathways induced by Klotho in MO3.13, a human oligodendrocytic hybrid cell line. We show that exogenous Klotho affects the ERK and Akt signaling pathways, decreases the proliferative abilities and enhances differentiation of MO3.13 cells. Furthermore, microarray analysis of Klotho-treated MO3.13 cells reveals a massive change in gene expression with 80 % of the differentially expressed genes being downregulated. Using gene set enrichment analysis, we predicted potential transcription factors involved in regulating Klotho-treated MO3.13 cells and found that these cells are highly enriched in the gene sets, that are similarly observed in cancer, cardiovascular disease, stress, aging, and hormone-related chemical and genetic perturbations. Since Klotho is downregulated in all brain tumors tested to date, enhancing Klotho has therapeutic potential for treating brain and other malignancies.

KW - Aging

KW - Apoptosis

KW - Cancer

KW - ERK

KW - Glia

KW - Myelin

KW - Signaling pathways

UR - http://www.scopus.com/inward/record.url?scp=84939885833&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939885833&partnerID=8YFLogxK

U2 - 10.1007/s12031-014-0336-1

DO - 10.1007/s12031-014-0336-1

M3 - Article

VL - 55

SP - 76

EP - 90

JO - Journal of Molecular Neuroscience

T2 - Journal of Molecular Neuroscience

JF - Journal of Molecular Neuroscience

SN - 0895-8696

IS - 1

ER -